This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.
The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
Biogen’s litifilimab has received Breakthrough Therapy Designation from the US FDA to treat cutaneous lupus erythematosus ...
Lucille, a 57 years old high school physical education coach, started experiencing a rash on her cheeks and nose. The rash worsened every time she went outside. She had been suffering from joint pain ...
Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous ...